// App-Quantinova.ai

: Multi-omic profiling in pulmonary arterial hypertension

Researchers

Presenter

  • Pablo Otero-Núñez

Principal Investigators

  • John Wharton

  • Emilia Swietlik

  • Sokratis Kariotis

  • Lars Harbaum

  • Mark Dunning

  • Jason Elinoff

  • Niamh Errington

  • Roger Thomson

  • James Iremonger

  • Gerry Coghlan

  • Paul Corris

  • Luke Howard

  • David Kiely

  • Colin Church

  • Joanna Pepke-Zaba

  • Mark Toshner

  • Stephen Wort

  • Ankit Desai

  • Marc Humbert

  • William Nichols

  • Laura Southgate

  • David-Alexandre Trégouët

  • Richard Trembath

  • Inga Prokopenko

  • Stefan Gräf

  • Nicholas Morrell

  • Dennis Wang

  • Allan Lawrie

  • Martin Wilkins

Medical Centers

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Department of Oncology, University of Cambridge, Cambridge, United Kingdom

  • Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, United Kingdom

  • Sheffield Bioinformatics Core, The University of Sheffield, Sheffield, United Kingdom

  • Critical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, United States of America

  • Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom,

  • Kings College London, London, United Kingdom

  • University of Newcastle, Newcastle, United Kingdom,

  • University of Glasgow, Glasgow, United Kingdom

  • Papworth Hospital, Papworth, United Kingdom

  • Indiana University, Indianapolis, Indiana, United States

  • Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay; AP-HP, Service de Pneumologie, Centre de référence de l’hypertension pulmonaire, Hôpital Bicêtre, Le Kremlin-Bicêtre; INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, Paris, France

  • Division of Human Genetics, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, United States of America

  • Molecular and Clinical Sciences Research Institute, St George’s, University of London

  • INSERM UMR_S 1219, Bordeaux Population Health Research Center, University of Bordeaux, Bordeaux, FRANCE

  • Divisions of Genetics and Molecular Medicine and Immunology,, King's College London, London, United Kingdom

  • Department of Clinical and Experimental Medicine, University of Surrey, Surrey, United Kingdom

Locations

  • United Kingdom

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Pulmonary arterial hypertension

Biomarkers

  • N/A

Drug/Treatment

  • Tamsulosin Hydrochloride

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A